4 Patents
- US125443792026Combination Therapy Using Ribociclib and Fulvestrant for the Treatment of HR+ Breast Cancer
Novartis AG
0 cites - US125443802026Combination Therapy Using Ribociclib and an Aromatase Inhibitor for the Treatment of HR+ Breast Cancer
Novartis AG
0 cites - 0 cites
- US116976252023Direct Synthesis of Light Olefins from Carbon Dioxide Using Yttria-stabilized Zirconia Support
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
0 cites